Skip to main content

Michael Liebman, Myra Williams, Michael Lack, David Clark

Premium

Michael Liebman is leaving his post as director of computational biology and biomedical informatics at the Abramson Cancer Center at the University of Pennsylvania to join the Windber Research Institute as chief scientific officer. Prior to joining the University of Pennsylvania, Liebman was global director of bioinformatics at Roche Bioscience.


ProSanos has appointed Myra Williams and Michael Lack to its board of directors. Williams, a consultant for pharmaceutical, biotechnology, IT, and bioinformatics companies, was formerly CIO for Glaxo and president and CEO of Molecular Applications Group. Lack is also a biotechnology and informatics consultant, and was most recently COO of Incyte Genomics (now Incyte).


David Clark, director of computer-aided drug design at Argenta Discovery, has been awarded the Corwin Hansch Award for his work on quantitative structure-activity relationships. The award — for scientists under 40 who have contributed significantly to QSAR — is presented by the QSAR and Modeling Society and consists of a citation and $1,000.

Filed under

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.